RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Qing Li to Gene Expression Regulation, Neoplastic

This is a "connection" page, showing publications Qing Li has written about Gene Expression Regulation, Neoplastic.
  1. Li QQ, Hao JJ, Zhang Z, Krane LS, Hammerich KH, Sanford T, Trepel JB, Neckers L, Agarwal PK. Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics. Sci Rep. 2017 03 15; 7(1):201.
    View in: PubMed
    Score: 0.098
  2. Li QQ, Hao JJ, Zhang Z, Hsu I, Liu Y, Tao Z, Lewi K, Metwalli AR, Agarwal PK. Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach. Int J Oncol. 2016 Jun; 48(6):2591-607.
    View in: PubMed
    Score: 0.092
  3. Li QQ, Lee RX, Liang H, Zhong Y. Anticancer activity of ?-Elemene and its synthetic analogs in human malignant brain tumor cells. Anticancer Res. 2013 Jan; 33(1):65-76.
    View in: PubMed
    Score: 0.073
  4. Hu B, Huang W, Wang R, Zang W, Su M, Li H, Wang H, Cao B, Deng D, Li QQ, Jiang J. High Rate of Detection of Human ESPL1-HBV S Fusion Gene in Patients With HBV-related Liver Cancer: A Chinese Case-Control Study. Anticancer Res. 2020 Jan; 40(1):245-252.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support